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Sydney Selwyn in his 1990 epic opening lecture to the Second 
International Conference of the Hospital Infection Society 
traced the history of hospital infection over 2 500 years!1  He 
reminded us of Florence Nightingale’s favourite dictum: ‘The 
first requirement of a hospital is that it should do the sick no 
harm’.
The scientific study of hospital or nosocomial cross-infection 
began during the first half of the 18th century, and from that 
time until the start of the ‘Bacteriological Era’, many of the 
most notable contributions originated in Scotland. Remarkable 
among these early pioneers was the physician Sir John Pringle, 
who strongly believed that overcrowding and poor ventilation 
added greatly to the problem of hospital infection. However, 
it was only 100 years later in 1858 that Florence Nightingale, 
following her experiences in military hospitals during the 
Crimean War, promoted the case for hospital reform, although 
she remained hostile to the ‘germ theory’ of disease for the 
remainder of her life.
Streptococcal and staphylococcal 
infections
The real understanding of hospital infection followed upon 
the discoveries of Pasteur, Koch and Lister, and the beginning 
of the ‘Bacteriological Era’. The close of the 19th century 
saw triumphs of hospital reform and asepsis and seemed to 
herald the final victory over hospital cross-infection. However, 
the victory was short-lived. With the opening of numerous 
hospitals for infectious diseases in the 20th century, it was 
soon realised that infections occurred not only in obstetric and 
surgical patients (the emphasis in the late 19th century) but 
in medical patients as well. It was soon realised that air could 
be a source of such infection and that many viral, as well as 
bacterial, infections spread via this route.
In the early part of the 1900s streptococcal cross-infection 
became a focus of attention. The dissemination of Streptococcus 
pyogenes by scarlet fever patients was clearly documented in 
1927, but it was not until the advent of serological typing of 
this bacterium that the high incidence of cross-infection in 
scarlet fever wards was confirmed by Gunn and Griffith.2 The 
epidemiology of puerperal fever due to S. pyogenes was also 
further elucidated by means of serological typing. This work 
fully established the importance of nasal and throat carriers 
in the transmission of streptococcal disease. It also showed 
that streptococcal infection occurred in burns and maternity 
wards and implicated airborne dust in the spread of infection. 
The period from 1935 to 1950, which was marked by intensive 
enquiry into streptococcal cross-infection, also saw a great 
decline in the importance of this type of infection. While much 
of this decline was almost certainly due to the introduction of 
the sulphonamides and penicillin, and by improved methods 
in hospital hygiene, the streptococcus was probably also 
undergoing a spontaneous decrease in virulence.
Hospital cross-infection due to Staphylococcus aureus, 
although of some importance before the end of the period 
in which the streptococcus dominated, really came into its 
own in the late 1950s and early 1960s. Bacteriophage typing 
of this bacterium clearly revealed that evolutionary changes 
had occurred over the years with increasing virulence. This 
culminated in the appearance of the notorious ‘phage 80/81 
staphylococcus’ in the 1960s, which resulted in epidemics of 
infection in many parts of the world. More recently, epidemic 
methicillin-resistant S. aureus (EMRSA) strains have emerged to 
produce clinical infections in many hospitals worldwide.3
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The scientific study of hospital or nosocomial cross-infection 
began during the first half of the 18th century, and from 
that time until the start of the ‘Bacteriological Era’ many 
of the most notable contributions originated in Scotland.   
However it was only 100 years later in 1858 that Florence 
Nightingale promoted the case for hospital reform.
The real understanding of hospital infection followed 
upon the discoveries of Pasteur, Koch and Lister and the 
beginning of the ‘Bacteriological Era’.
The close of the 19th century saw the triumphs of hospital 
reform and asepsis and seemed to herald the final victory 
over hospital cross-infection.
However, the victory was short-lived. It was soon realised 
that infections occurred not only in obstetric and surgical 
patients, but in medical patients as well, and that air could 
also be a source of  infection.
Streptococcal, staphylococcal and then Gram-negative 
bacilli as a cause of hospital infection became a focus of 
attention, as did antibiotic-resistant organisms.
This paper looks briefly at the establishment of the control 
of infection doctor, infection control committee and infection 
control nurse as well as summarising the changes, problems 
and advances in infection control up to the present time.
Corresponding author: A A Forder (ndp@sun.ac.za)
Pg 1161-1164.indd   1161 11/2/07   10:22:52 AM
November 2007, Vol. 97, No. 11  SAMJ
ORIGINAL ARTICLES
The rise of Gram-negative infections
The importance of Gram-negative bacilli as a cause of hospital 
infection increased insidiously during the 1950s and had 
overtaken that of S. aureus by 1960. However, this event was 
not widely appreciated until comprehensive surveys had been 
conducted in the 1960s.4 Escherichia, Klebsiella, Proteus and 
Pseudomonas species and related genera, which possess very 
limited pathogenic abilities in the healthy host, were found 
to be well suited to their increasing role in hospital infection. 
Important factors were their considerable powers of resistance 
to antibiotics and disinfectants, and their ability to survive 
and even multiply under adverse environmental conditions. 
They were particularly suited to colonising and infecting 
debilitated patients, and the apparatus used on such patients. 
The introduction of broad-spectrum antibiotics hastened the 
emergence of highly resistant strains of Pseudomonas species, 
which rapidly became a major pathogen in the 1960s. This 
resistant organism was soon followed by resistant strains of 
Serratia and Acinetobacter. The age of opportunistic organisms 
had arrived. 
Infection control doctors and nurses
It is interesting to note that the challenge of increasingly 
complex and expensive hospital infection problems over 
the past 60 years led to the development of a structured 
system of control. In the UK the first formal step was the 
recommendation in 1941 by the British Medical Research 
Council (MRC) that for the prevention of surgical sepsis, ‘full-
time special officers’ should be appointed to supervise the 
control of infection.5 Thus was born the part-time control of 
infection officer (CIO), renamed in 1988 the infection control 
doctor (ICD). Then in 1944 the MRC advised that in every 
hospital an infection control committee be established with 
representative doctors, nurses and administrators. In the 
mid-1950s, Brendan Moore in Exeter developed the idea of 
an infection control nurse (ICN) (or sister) to assist the CIO.6 
The first ICN in the UK was appointed in 1959. ICNs were 
appointed in South Africa at a much later stage.
It is now regular practice in most large hospitals worldwide 
to employ ICNs and to have established infection control 
committees with a mandate to monitor and prevent hospital-
acquired infections. It is of interest to look back over the last 18 
years to note what developments have taken place in the area 
of hospital-acquired infection.
Second International Conference on 
Nosocomial Infections – Atlanta, 1980
In August 1980, the Second International Conference on 
Nosocomial Infections was held in Atlanta, Georgia, USA. 
Richard Dixon, in his preface to the conference proceedings, 
drew attention to how the discovery of antimicrobial agents 
had made it seem likely in the late 1940s and early 1950s 
that hospital-acquired infections would fade in importance.7 
However, the surge of staphylococcal infections that occurred 
throughout the world in the next decade proved that these 
infections remained important, and their occurrence gave 
impetus to renewed epidemiological and clinical research. Thus 
was spawned the First International Conference on Nosocomial 
Infections, held in Atlanta in 1970.8 In closing this conference, 
Sir Robert E O Williams reflected that ‘one of the principal 
reasons that we have so often failed to persuade our colleagues 
in hospitals to do the antiseptic things that we think they ought 
to do, is that we have so rarely provided them with convincing 
evidence that if they do, their patients will get better more 
quickly or survive in significantly greater numbers’, and 
he challenged his audience to evaluate scientifically the 
control measures that had been recommended to date.9 The 
10 years following that first meeting in Atlanta showed that 
infection control as a discipline had grown rapidly, and indeed 
three new journals devoted to infection control made their 
appearance, including the Journal of Hospital Infection. Theodore 
Eickhoff, in the keynote address given to the Atlanta meeting 
in 1980 entitled ‘Nosocomial infections – a 1980 view: Progress, 
priorities and prognosis’, noted that progress had been made 
in a few efficiency studies, emphasised the determinative 
role of the host in infections, stressed the concept of 
immunoincompetence, emerging pathogens such as Legionnella 
pneumophila, the epidemiology of antimicrobial drug resistance 
and the concept of chemoprophylaxis. Major advances had 
also been made in preventing a few specific nosocomial 
infections such as hepatitis B. The evolving roles of ICDs, ICNs 
and hospital epidemiologists had been consolidated.10 Major 
failures of the preceding decade (1970 - 1980) had included 
the continuing absence of an acceptable scientific basis for 
infection control, the lack of standards for such control and the 
consequent inability to carry out effective education.
First International Conference of the 
Hospital Infection Society, 1987
Seven years later, this time in London, UK, the First 
International Conference of the Hospital Infection Society 
was inaugurated.11 In his opening address, Ian Phillips noted 
that one of the strongest characteristics of hospital infection 
was its continued evolution. ‘Not only does the procession 
of pathogens continue to recruit and regroup, but also fresh 
opportunities for invasion arise regularly as medicine tackles 
ever more complex problems, coincidentally lowering the 
patient’s barriers to infection’. The evolution of organisms 
involved in hospital infection has been extensively documented 
over the past years and there seems little reason to suppose 
that the variety of species and their susceptibility to antibiotics 
will not continue to expand and that the importance of 
individual species will wax and wane. In addition to the 
familiar, it seems entirely possible that there will be new 
pathogens awaiting discovery. The task of detecting these 
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organisms will fall to the microbiologists in diagnostic 
laboratories of all types and it is essential that this major role 
should be recognised.12
Second International Conference of the 
Hospital Infection Society, 1990
September 1990 saw the Second International Conference of 
the Hospital Infection Society.13 There was an emphasis on 
the price of hospital infection, including new strategies for 
antimicrobial use, disinfection and sterilisation of instruments 
contaminated with viruses, and the impact of molecular 
biology on hospital infections.
Third International Conference on 
Hospital Infection, 1994
The Third International Conference of the Hospital Infection 
Society was held in September of 1994.14 Again there was a 
resurfacing of a number of older problems. Resource utilisation 
and infection control topped the list, followed by advances 
in preventing implant infections, the challenge of setting and 
achieving standards in hospital infection control, and risk 
factors in surgical infection;  viral hazards to and from health 
care workers, multiresistant mycobacterial infections and 
ventilator-associated pneumonia were important additional 
topics.
More recently, antibiotic-resistant pathogens not 
seen previously have emerged, particularly in the 
immunocompromised host. Some of these more important 
emerging pathogens have included Enterococcus species 
(especially E. faecium), S. viridans, resistant Gram-negative 
organisms (Klebsiella spp., Citrobacter spp., Enterobacter spp.), 
and resistant Candida species.
Fourth International Conference of the 
Hospital Infection Society, 1998
The Fourth International Conference of the Hospital Infection 
Society was held in Edinburgh in 1998.15 It was clear from 
this meeting that old topics had surfaced again but now with 
greater insight and better methods of diagnosis and control. 
Antibiotic resistance in Gram-positive organisms was a main 
theme of the meeting, with vancomycin resistance and MRSA 
isolates causing concern.
The difficulty of inactivating prions by both physical and 
chemical methods was highlighted in an important paper by D 
M Taylor.16
Indwelling devices and prostheses again received attention 
and the question of S. epidermidis (coagulase-negative 
staphylococci) and biofilm formation was discussed. Infectious 
diseases and litigation was an important topic, as was a paper 
concerning nosocomial infections in HIV-infected/AIDS 
patients.
Because fever and infection are so common during periods 
of chemotherapy-induced neutropenia in cancer patients, 
antimicrobial prophylaxis has become a common practice. 
Currently oral quinolones are used in many centres for this 
purpose. However, there are two significant problems with 
quinolone prophylaxis; the first is the limitation of coverage of 
these agents that excludes most Gram-positive bacteria (some 
of the newer agents have better cover), and the second is the 
emergence of resistance in susceptible bacteria.
Viridans streptococci and resistance to 
quinolones
Among those bacteria that are not inhibited by quinolones are 
viridans streptococci. In the past these have seldom caused 
serious infections in neutropenic patients and have responded 
to a variety of antibacterial regimens, but in recent years they 
have emerged as a cause of significant infections. The routine 
administration of antacids or H2-antagonists may be another 
important risk factor. Several studies have demonstrated that 
the concentration of organisms recovered from the stomach 
increases with increasing pH, and Gram-positive bacteria are 
predominant among them. These serious viridans streptococcal 
infections are of special concern because they may cause renal 
failure or acute respiratory distress syndrome resulting in the 
death of the patient, after the acute infection appears to have 
been controlled.
Although the majority of infections diagnosed are cases of 
bacteraemia, some patients develop serious infections such 
as pneumonia, skin, and urinary tract infections. Leukaemia 
patients appear to be at special risk of infection.
Emergence of ‘new’ Gram-positive 
bacteria
Over the past 14 years several Gram-positive bacteria have 
emerged as pathogens in immunocompromised hosts, and 
especially among neutropenic patients. Among these are 
Corynebacterium jeikeium, Bacillus cereus, S. hemolyticus and 
Leuconostic sp. These organisms typically have two factors 
in common. Most of the infections are associated with 
indwelling intravascular catheters and the organisms are 
resistant to β-lactam antibiotics. In some series, fatality rates 
have approached 50%. In general, the only antimicrobial 
agent consistently effective in eradicating these infections is 
vancomycin.
Fungal pathogens
For many years the most common fungal pathogens among 
immunocompromised hosts were Candida spp. and Aspergillus 
spp. Although several fungi have emerged as important 
pathogens in recent years, the most disturbing of these are 
Fusarium spp.
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Candida spp. have emerged as a significant cause of 
infection in a variety of immunocompromised hosts, but 
especially among HIV-infected patients, leukaemic patients 
and organ-transplant recipients. Whereas HIV-infected 
patients tend to have only superficial infections, such as 
oropharyngitis, oesophagitis and vaginitis, their frequent 
recurrence can represent a major cause of discomfort and a 
difficult management problem. Leukaemia and transplant 
patients are more likely to develop fungaemias, major organ 
and disseminated infection, but are less likely to experience 
frequent recurrence of infection. Resistance to antifungal 
therapy has not presented a significant problem until recently. 
Of great concern is the problem of emergence of resistance 
to fluconazole in C. albicans and other generally susceptible 
species among the AIDS population.
Tuberculosis
For a number of years a progressive decrease was observed 
in the incidence of tuberculosis in the Western world, but that 
trend has changed. This is partly caused by the frequency 
of infection among AIDS patients, but more alarmingly 
because of the increase in multiple-drug-resistant strains of 
Mycobacterium tuberculosis. There is great concern regarding 
the potential for spread of these resistant strains not only 
to other immunocompromised hosts but also to health care 
workers and the general population. Because of the increasing 
prevalence of multiple-drug-resistant strains and their role in 
immunocompromised hosts, there is a desperate need for new 
antituberculosis agents. The recent emergence of extremely 
drug-resistant tuberculosis (XDR-TB) is of great concern and 
highlights the problem of ineffective treatment.
The emergence of resistant organisms as a cause of serious 
infection in the immunocompromised host requires a re-
examination of our infection control practices. Possibly 
air delivery systems must be installed to control spread 
of an airborne pathogen such as M. tuberculosis. Antibiotic 
practices need to be re-examined to avoid excessive and 
inappropriate use of drugs, such as vancomycin, before 
widespread epidemics of untreatable infections occur. Health 
care personnel need to become compulsive about careful 
hand-washing procedures. Recent studies continue to reinforce 
previous evidence that compliance with hand-washing 
procedures is suboptimal.
Clostridium difficile and enterococcal 
bacteraemia
Recent publications, international reports and supplements to 
journals covering hospital-acquired infections have discussed 
and commented upon Clostridium difficile,17 glycopeptide-
resistant enterococcal bacteraemia,18 and more recently 
guidelines for preventing health care-associated infections 
in NHS hospitals in the UK.19 These guidelines are of special 
interest, covering as they do standard principles for preventing 
health care-associated infections in hospitals and other acute 
care settings, guidelines for preventing infections associated 
with the use of short-term urethral catheters, and guidelines for 
preventing infections associated with the use of central venous 
access devices. There have also been evidence-based guidelines 
for preventing health care-associated infections in primary and 
community care in England.20
Sixth International Conference of the 
Hospital Infection Society, 2006
The Sixth International Conference of the Hospital Infection 
Society was recently held in Amsterdam in October 2006,21 and 
again, MRSA and all its ramifications held centre-stage.
This brief overview of the history of infection control draws 
attention to the many challenges that lie ahead. Although 
hospital infection control has been accepted in theory as an 
important and necessary discipline in most hospitals in the 
world, the practical application of the principles involved 
in such control is often conspicuous by its absence. There is 
need to convince the health authorities that money and time 
spent on the implementation of effective and efficient infection 
control programmes is money and time well spent.
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